Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2011

View Archived Issues

New cannabinoid CB2 receptor agonists discovered

AstraZeneca patents new diacylglycerol O-acyltransferase 1 inhibitors

New melanin-concentrating hormone MCH1 receptor antagonists disclosed

Merck & Co. claims novel gamma-secretase modulators

Chimerix begins enrollment in open-label study of CMX-001

Antimalarial artesunate has anticancer properties that can be enhanced by combination therapy

PC-1005 gel protects monkeys from infection with simian HIV

Studies examine pharmacodynamics and antidepressant efficacy of LY-2216684

Zydus-Cadila discloses new GPR119 receptor agonists

Immutep and GSK enter into agreement for ImmuTune IMP-731

Cylene Pharmaceuticals identifies novel protein kinase inhibitors

Isis expands pipeline with ISIS-STAT3Rx and ISIS-FGFR4Rx

NPS Pharma concludes treatment in phase III STEPS trial of Gattex

CeNeRx BioPharma begins phase II trial of modified-release CX-157

Daiichi Sankyo launches Cravit intravenous injections in Japan

MacroGenics begins phase I study of MGAH-22 in HER2-positive tumors

Bristol-Myers Squibb and Pharmasset to evaluate combination treatment for chronic hepatitis C

Phase III trial begins for lubiprostone in opioid-induced bowel dysfunction

Seattle Genetics and Pfizer join to develop anticancer antibody-drug conjugates

New unbiased approach described for discovery of IgG biomarkers with diagnostic potential

Esperion begins phase II trial of ETC-1002 in lipid regulation

Phase II data reported on LCP-Tacro in de novo liver transplant recipients

Dara BioSciences presents additional data from phase I DB-959 trial

EffRx Pharma submits NDA to FDA for EX-101

FDA grants marketing approval for diaDexus' automated PLAC test

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...